Y-mAbs Therapeutics Investors Get Final OK For $19.7M Deal

By Sydney Price · October 29, 2024, 10:18 PM EDT

A New York federal judge has granted final approval to a $19.7 million settlement between Y-mAbs Therapeutics and investors who claim the company misrepresented the likelihood that the U.S. Food and...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Corwin v. Y-mAbs Therapeutics, Inc. et al

Case Number

1:23-cv-00431

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

January 18, 2023